UBS Group AG - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,416,000
+141.4%
99,157
+17.1%
0.00%0.0%
Q2 2020$1,415,000
+57.6%
84,674
+36.0%
0.00%
Q1 2020$898,000
-18.9%
62,239
+88.2%
0.00%
Q4 2019$1,107,000
-48.9%
33,064
-68.0%
0.00%
-100.0%
Q3 2019$2,167,000
+188.9%
103,480
+187.2%
0.00%
Q2 2019$750,000
+97.9%
36,031
+112.6%
0.00%
Q1 2019$379,000
-81.3%
16,949
-80.0%
0.00%
-100.0%
Q4 2018$2,029,000
+695.7%
84,843
+809.0%
0.00%
Q3 2018$255,000
-0.8%
9,334
-2.4%
0.00%
Q2 2018$257,000
-95.3%
9,564
-94.5%
0.00%
-100.0%
Q1 2018$5,514,000
+989.7%
173,234
+1193.9%
0.00%
Q4 2017$506,000
+13.5%
13,388
-25.6%
0.00%
Q3 2017$446,000
+187.7%
17,993
+138.5%
0.00%
Q2 2017$155,000
+675.0%
7,544
+702.6%
0.00%
Q1 2017$20,000
-72.6%
940
-73.7%
0.00%
Q4 2016$73,000
+3550.0%
3,577
+3477.0%
0.00%
Q3 2016$2,0000.0%100
-44.4%
0.00%
Q2 2016$2,000
-93.3%
180
-92.0%
0.00%
Q1 2016$30,000
+172.7%
2,241
+273.5%
0.00%
Q4 2015$11,000
-26.7%
6000.0%0.00%
Q3 2015$15,0006000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders